Show
Sort by
-
- Journal Article
- A1
- open access
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP
-
- Conference Paper
- C3
- open access
Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps and comorbid asthma from the pooled populations of the SINUS-24 and SINUS-52 Dupilumab phase 3 trials
-
Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS-24 and SINUS-52 phase 3 studies
-
Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis
-
Omalizumab responders analysis in nasal polyposis : a supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials
-
Continued safety / efficacy of omalizumab in chronic rhinosinusitis with nasal polyps : an open-label extension study
(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S15-S15 -
- Journal Article
- A1
- open access
Treatment of allergic rhinitis during and outside the pollen season using mobile technology : a MASK study
-
- Journal Article
- A1
- open access
Aligning the good practice MASK with the objectives of the European Innovation Partnership on Active and Healthy Ageing
-
European position paper on rhinosinusitis and nasal polyps 2020
-
Dupilumab improves patient-reported outcomes in chronic Rhinosinusitis with nasal polyps and comorbid asthma : sinus-24/sinus-52 trials